Prospective Evaluation of Pregnancy-Associated Plasma Protein-A and Outcomes in Patients With Acute Coronary Syndromes

Abstract
No abstract available
Funding Information
  • Accumetrics
  • AstraZeneca
  • Bayer HealthCare
  • Beckman Coulter
  • Biosite
  • Bristol-Myers Squibb
  • CV Therapeutics
  • Daiichi Sankyo
  • Eli Lilly Co.
  • GlaxoSmithKline
  • Merck & Co.
  • Nanosphere
  • Novartis Pharmaceuticals
  • Ortho-Clinical Diagnostics
  • Pfizer
  • Roche Diagnostics
  • Sanofi-Aventis
  • Schering-Plough
  • Siemens
  • Singulex
  • Gilead
  • AstraZeneca
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Merck & Co.
  • Johnson & Johnson
  • Bayer HealthCare
  • GlaxoSmithKline
  • Novartis
  • National Health, Lung, and Blood Institute (R01 HL096738, R01 HL098280)
  • Beckman-Coulter
  • Amgen
  • Brahms
  • Daiichi Sankyo
  • Merck & Co.
  • Abbott
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Merck
  • AstraZeneca
  • Johnson & Johnson
  • Beckman Coulter
  • Eli Lilly Co.
  • Roche Diagnostics
  • Sanofi-Aventis
  • Daiichi Sankyo
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Amgen
  • Critical Diagnostics
  • Integrated Therapeutics
  • Millennium Pharmaceuticals
  • Novelo
  • Sanofi-Synthelab

This publication has 25 references indexed in Scilit: